Contact your GP, trial coordinator, or a healthcare professional promptly but without the urgency of 999 if you experience: A widespread or rapidly spreading rash, particularly if accompanied by fever, joint pain, or malaise Blistering, peeling, or open sores on the skin, which may indicate a more serious dermatological reaction Persistent or worsening injection site reactions that do not resolve within a few days Skin changes accompanied by systemic symptoms such as fatigue, fever, or lymph node swelling Severe cutaneous adverse reactions (SCARs), such as Stevens-Johnson syndrome or toxic epidermal necrolysis, are rare but serious drug-related skin conditions requiring emergency assessment
Gholipour Baradari, A., Alipour, A., Mahdavi, A., Sharifi, H., Nouraei, S
It binds to growthhormone secretagogue receptors (GHSR) in the hypothalamus and pituitary, reduces the inhibitory signal from somatostatin, and triggers a rapid GH pulse
"After Eight-Month Review, EMA Finds No Link Between GLP-1 Usage and Suicidal Thoughts." Fierce Pharma, April 12, 2024